Antioxidants to prevent bovine neutrophil-induced mammary epithelial cell damage.
Activated neutrophils are able to produce a large quantity of bactericidal molecules such as reactive oxygen species that have been associated with tissue damage in several inflammation models. The protective effects of antioxidants in a context of neutrophil-induced damage to mammary epithelial cells were first evaluated in vitro using a coculture model of activated bovine neutrophils and a bovine mammary epithelial cell line (MAC-T cells). Cell damage was determined by quantifying the release of lactate dehydrogenase by MAC-T cells in culture medium. Morphological observation of cells stained with acridine orange was used to visualize the extent of cell damage. When incubated with neutrophils activated by lipopolysaccharides and phorbol 12-myristate 13-acetate, MAC-T cells released large amounts of lactate dehydrogenase indicating significant cell damage. The addition of dimethylthiourea or bathocuproine disulfonic acid did not reduce the damage whereas catechin, deferoxamine or glutathione ethyl ester significantly reduced neutrophil-induced cytotoxicity in a dose-dependent manner. The effect of deferoxamine, an iron chelator, on the growth of Escherichia coli and the ability of bovine neutrophils to phagocytose these bacteria were then assessed in vitro. Our data showed that deferoxamine did not interfere with the phagocytic activity of neutrophils but inhibited growth of the bacteria. Overall, our results suggest that antioxidants may be effective tools for protecting mammary tissue against neutrophil-induced oxidative stress during bovine mastitis.
Lauzon
K
K
Dairy and Swine Research and Development Centre, Agriculture and Agri-Food Canada, Lennoxville, Québec, J1M 1Z3, Canada.
Zhao
X
X
Bouetard
A
A
Delbecchi
L
L
Paquette
B
B
Lacasse
P
P
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D003676:Deferoxamine / Q000494:pharmacology; D004847:Epithelial Cells / Q000502:physiology*; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D005260:Female; D007502:Iron Chelating Agents / Q000494:pharmacology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008321:Mammary Glands, Animal / Q000166:cytology*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D010587:Phagocytosis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000975:Antioxidants; D007502:Iron Chelating Agents; D008070:Lipopolysaccharides; D007770:L-Lactate Dehydrogenase; D003676:Deferoxamine; D013755:Tetradecanoylphorbol Acetate